General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 7, 2015, Pages 1284-1290

  Saliba, Rima M ^a   Rezvani, Katayoun ^a   Leen, Ann ^b   Jorgensen, Jeffrey ^a   Shah, Nina ^a   Hosing, Chitra ^a   Parmar, Simrit ^a   Oran, Betul ^a   Olson, Amanda ^a   Rondon, Gabriela ^a   Chen, Julianne ^a   Martinez, Charles ^a   Hamdi, Amir ^a   Mehta, Rohtesh S ^a   Chemaly, Roy F ^a   Saunders, Ila M ^c   Bollard, Catherine M ^d   Shpall, Elizabeth J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Absolute lymphocyte count; B cells; NK cells; Post transplant; Post transplant infections; T cells

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS ANTIGEN; LYMPHOCYTE ANTIBODY; MYELOABLATIVE AGENT;

ADENOVIRIDAE; ADULT; ARTICLE; B LYMPHOCYTE; BK VIRUS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS; DOUBLE CORD BLOOD TRANSPLANTATION; DRUG DOSE REDUCTION; ENGRAFTMENT; EPSTEIN BARR VIRUS; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA VIRUS; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NATURAL KILLER CELL; OVERALL SURVIVAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECIPIENT; T LYMPHOCYTE; VIRUS INFECTION; VIRUS REACTIVATION; ADOLESCENT; ADVERSE EFFECTS; AGED; HEMATOLOGIC NEOPLASMS; IMMUNOLOGY; PATHOLOGY; PROCEDURES; RISK; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIROLOGY; VIRUS DISEASES;

ADOLESCENT; ADULT; AGED; ANTIGENS, VIRAL; ANTILYMPHOCYTE SERUM; B-LYMPHOCYTES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 84929005503     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.02.017     Document Type: Article

References (41)

1. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. NEngl J Med 1997, 337:373-381.
2. Escalon M.P., Komanduri K.V. Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution. Curr Opin Oncol 2010, 22:122-129.
3. Kanda J., Chiou L.W., Szabolcs P., et al. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012, 18:1664-1676.
4. Sanz J., Sanz M.A., Saavedra S., et al. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. Biol Blood Marrow Transplant 2010, 16:86-94.
5. Kurtzberg J., Laughlin M., Graham M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. NEngl J Med 1996, 335:157-166.
6. Kim Y.J., Broxmeyer H.E. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol 2011, 79:112-126.
7. Danby R., Rocha V. Improving engraftment and immune reconstitution in umbilical cord blood transplantation. Front Immunol 2014, 5:68.
8. Rocha V., Wagner J.E., Sobocinski K.A., et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. NEngl J Med 2000, 342:1846-1854.
9. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. NEngl J Med 2004, 351:2276-2285.
10. Brunstein C.G. Umbilical cord blood transplantation for the treatment of hematologic malignancies. Cancer Control 2011, 18:222-236.
11. Brunstein C.G., Fuchs E.J., Carter S.L., et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011, 118:282-288.
12. Brunstein C.G., Eapen M., Ahn K.W., et al. Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood 2012, 119:5591-5598.
13. Gutman J.A., Leisenring W., Appelbaum F.R., et al. Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis. Biol Blood Marrow Transplant 2009, 15:1122-1129.
14. Milano F., Pergam S.A., Xie H., et al. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. Blood 2011, 118:5689-5696.
15. Cutler C., Stevenson K.F., Kim H.T, et al. Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Biol Blood Marrow Transplant 2011, 46:659-667.
16. Komanduri K.V., St John L.S., de Lima M., et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007, 110:4543-4551.
17. Szabolcs P., Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007, 9:111-122.
18. Niehues T., Rocha V., Filipovich A.H., et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children-a Eurocord analysis. Br J Haematol 2001, 114:42-48.
19. Thomson B.G., Robertson K.A., Gowan D., et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000, 96:2703-2711.
20. Klein A.K., Patel D.D., Gooding M.E., et al. T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001, 7:454-466.
21. Ruggeri A., Peffault de L.R., Carmagnat M., et al. Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases. Transpl Infect Dis 2011, 13:456-465.
22. Jacobson C.A., Turki A.T., McDonough S.M., et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2012, 18:565-574.
23. Somers J.A., Brand A., van Hensbergen Y., et al. Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies. Biol Blood Marrow Transplant 2013, 19:266-273.
24. de Lima M., McNiece I., Robinson S.N., et al. Cord-blood engraftment withexvivo mesenchymal-cell coculture. NEngl J Med 2012, 367:2305-2315.
25. Sarantopoulos S., Stevenson K.E., Kim H.T., et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood 2009, 113:3865-3874.
26. Porrata L.F., Gertz M.A., Inwards D.J., et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 2001, 98:579-585.
27. Porrata L.F., Litzow M.R., Tefferi A.F., et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 2002, 16:1311-1318.
28. Einsele H., Ehninger G., Steidle M., et al. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 1993, 82:1672-1678.
29. Chakrabarti S., Mautner V., Osman H., et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002, 100:1619-1627.
30. Chakrabarti S., Collingham K.E., Marshall T., et al. Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity. Transplantation 2001, 72:1460-1463.
31. Kim D.H., Kim J.G., Sohn S.K., et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 2004, 125:217-224.
32. Kumar S., Chen M.G., Gastineau D.A., et al. Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia. Leukemia 2003, 17:1865-1870.
33. Moretta A., Maccario R., Fagioli F., et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001, 29:371-379.
34. Beck J.C., Wagner J.E., DeFor T.E., et al. Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol Blood Marrow Transplant 2010, 16:215-222.
35. Brunstein C.G., Weisdorf D.J., DeFor T., et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006, 108:2874-2880.
36. Scheurer M.E., Pritchett J.C., Amirian E.S., et al. HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transplant 2013, 48:574-580.
37. Silva L.P., Patah P.A., Saliba R.M., et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 2010, 95:1183-1190.
38. Storek J., Joseph A.F., Espino G.F., et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 2001, 98:3505-3512.
39. Lindemans C.A., Chiesa R.F., Amrolia P.J., et al. Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome. Blood 2014, 123:126-132.
40. Small T.N., Papadopoulos E.B., Boulad F.F., et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999, 93:467-480.
41. Hanley P.J., Cruz C.R., Shpall E.J., Bollard C.M. Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood. Cytotherapy 2010, 12:713-720.